Aayush Wellness shares hit their upper circuit limit at RS. 154.05, rising by 3.00 points or 1.99% from the previous close of RS. 151.05 on the BSE.

The stock opened at RS. 154.05 and remained at that level throughout the session, marking both the day's high and low. A total of 62,437 shares were traded on the counter.

Classified under the BSE group 'XT', the stock with a face value of RS. 1 reached its 52-week high of RS. 154.05 on June 10, 2025, and a 52-week low of RS. 16.81 exactly one year earlier, on June 10, 2024. Over the past week, the scrip recorded a high of RS. 154.05 and a low of RS. 142.40. The company's current market capitalization stands at RS. 749.79 crore.

Non-institutional investors currently hold 100% of the company's shares.

In a major strategic move, Aayush Wellness has secured approval from its Board of Directors to establish a wholly owned subsidiary in Singapore, with an initial capital investment of SGD 10,000. This marks a critical step in the company’s international expansion and is aimed at launching its nutraceutical and healthcare products across the fast-growing Southeast Asian region.

The new subsidiary will focus on adapting products to local market preferences and regulations, building partnerships and e-commerce networks within ASEAN countries, boosting exports from India, enhancing global brand visibility, and setting up a regional R&D hub to tailor wellness solutions to local trends.

Aayush Wellness continues to lead in health and wellness innovations, offering a wide range of solutions that combine science, nature, and wellbeing.